Aspired Steps

Tag: 30-month stay

30-Month Stay Explained: How Patent Litigation Delays Generic Drug Approval
Drug Safety & Monitoring
30-Month Stay Explained: How Patent Litigation Delays Generic Drug Approval

Explore how the 30-month stay under the Hatch-Waxman Act delays generic drug approval through patent litigation, impacting costs and market access.

Read More
Aspired Steps

Latest Posts

Contact Us

SEND MESSAGE